Furthermore, the low expression level of MEG3 has been correlated with poor prognosis in cervical cancer, meningioma, gastric cancer, colorectal cancer, and breast cancer[[8], [9], [10], [11], [12]]. Here, MEG3 is linked to breast carcinoma.